What to expect from topical calcineurin inhibitors for hypopigmentation

Hypopigmentation means an area of skin has less colour than the surrounding skin. It can follow inflammation, eczema, irritation, infection, or another skin condition. Calcineurin inhibitors such as tacrolimus or pimecrolimus reduce certain inflammatory signals in the skin. They do not add pigment directly, so they are useful only when inflammation is part of the reason the patch looks lighter.

The patch may remain lighter for a while after the inflammation settles because pigment-making cells need time to restore colour. The response can vary by body area, skin tone, cause, and whether the original condition is still active. A clinician may reassess the diagnosis if the patch spreads, changes texture, or does not respond as expected.

Apply a thin layer only to the areas your prescriber identified, following the prescribed schedule. Wash your hands before and after application, unless the hands are the treated area. Mild warmth, stinging, or redness can occur early and often settles, but persistent or troublesome irritation should be reported.

Protect lighter patches from excessive sun exposure. Sunburn can irritate treated skin, and tanning can make the colour contrast more noticeable. Avoid applying the medicine to infected, broken, or severely irritated skin unless your clinician has given specific instructions. Do not cover the area with an occlusive dressing unless advised.

Keep follow-up appointments so the clinician can check both the cause of the colour change and the skin's response. Take note of new symptoms, spreading patches, or changes in texture rather than stopping or increasing treatment on your own.

Contact your prescriber if burning or itching is severe, if redness continues, or if the treated area develops crusting, oozing, blisters, or increasing pain. Seek prompt medical advice for rapidly spreading colour loss, a new change involving the eyes or mouth, or a patch with numbness or marked scaling.

Arrange a review if the diagnosis is uncertain or the patches continue to appear despite treatment. These signs do not identify one specific cause, but they can mean the skin needs examination and a different treatment plan.

Ask what is causing the hypopigmentation and what improvement would look like for your skin. You can also ask how often to apply the medicine, which reactions are expected, when the treatment should be reviewed, and whether other products or sun protection should be used with it.